Roger Zaldivar

About Roger Zaldivar

In the period from roughly August 2024 to February 2026, Roger Zaldivar's efforts have been driven by a desire to bridge clinical practice with cutting-edge technology, particularly AI and big data, to enhance safety, precision, and patient-centered outcomes in refractive and cataract surgery. Building on his family legacy (his father pioneered phakic IOLs), Zaldivar's motivation stems from addressing longstanding challenges like inaccurate phakic lens sizing, suboptimal patient satisfaction, and limited access to real-world evidence in ophthalmology. He has emphasized democratizing advanced tools for global clinics, while expanding data-driven insights beyond refractive procedures to areas like retina, glaucoma, and dry eye. Zaldivar's work has had tangible impacts, including the widespread adoption of ICLGuru—an AI-powered tool for phakic IOL sizing using ultrasound biomicroscopy (UBM) data. By late 2025, ICLguru was adopted by over 450 clinics in 60+ countries, serving thousands of patients monthly with high vault prediction accuracy, reduced sizing errors and complications like excesive vaulting, and broader eligibility for extreme cases.

Through RevaiCare, an AI-powered digital health platform, Zaldivar has compiled extensive datasets of patient-reported outcome measures (PROMs), offering real-world insights into IOL performance and patient satisfaction. A 2025 study validated its AI for postoperative predictions, fostering multi-center collaborations. Now active in over 20 countries, the platform is expanding standardized care across subspecialties like retina, glaucoma, dry eye, cataract, and refractive surgery—aiming to transform decision-making in eye health.